CAS 917909-70-7 | BIT-225-003 : BIT-225

CAS 917909-70-7 | BIT-225-003 : BIT-225
(World's Largest Pharmaceutical Supplier)

  • CAS Number: 917909-70-7
  • Stock: 999g
  • Assay: 0.00%

Abstract:

CAS 917909-70-7 is a chemical compound that belongs to the class of heterocyclic compounds. This compound has gained significant attention due to its potential applications in the pharmaceutical industry. In this article, we will discuss the chemical properties and various applications of CAS 917909-70-7.


1. Chemical Properties:

CAS 917909-70-7 has a molecular formula of C21H24N2O and a molecular weight of 324.43 g/mol. This compound has a melting point of 140-142°C and is soluble in organic solvents such as methanol and ethanol. It is a yellowish solid that is stable under normal conditions.


2. Applications:

CAS 917909-70-7 has been found to have potential applications in the pharmaceutical industry. It has been identified as a potent inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). DPP-4 inhibitors are used in the treatment of type 2 diabetes as they help reduce blood glucose levels. Studies have shown that CAS 917909-70-7 has higher inhibitory activity against DPP-4 than other known inhibitors.


In addition to its use as a DPP-4 inhibitor, CAS 917909-70-7 has also been investigated for its anti-inflammatory and analgesic properties. It has been found to have significant anti-inflammatory effects in animal models of inflammation. This suggests that it may have potential applications in the treatment of inflammatory disorders such as rheumatoid arthritis.


CAS 917909-70-7 has also been investigated for its potential as an anti-cancer agent. Studies have shown that it has anti-proliferative effects on cancer cells and may be useful in the treatment of various types of cancer.


Conclusion:

CAS 917909-70-7 is a chemical compound with potential applications in the pharmaceutical industry. Its high inhibitory activity against DPP-4 and anti-inflammatory properties make it a promising candidate for the treatment of type 2 diabetes and inflammatory disorders. Further research is needed to fully understand its potential as an anti-cancer agent.